NDC 73293-0002 – Bupivacaine Hydrochloride
Bupivacaine Hydrochloride 7.5 mg/mL · Injection · Subarachnoid
Product NDC73293-0002
Product details
- Brand name
- Bupivacaine Hydrochloride
- Generic name
- Bupivacaine hydrochloride
- Labeler
- Huons Co., Ltd.
- Dosage form
- Injection
- Route
- Subarachnoid
- Marketing category
- ANDA · ANDA212822
- Marketed since
- December 30, 2019
- Listing expires
- December 31, 2026
- Pharmacologic class
- Amide Local Anesthetic
Active ingredients
- Bupivacaine Hydrochloride 7.5 mg/mL
Uses, dosage, side effects and warnings for Bupivacaine Hydrochloride →
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 73293-0002-2 | 50 AMPULE in 1 PACKAGE (73293-0002-2) / 2 mL in 1 AMPULE (73293-0002-1) | Dec 30, 2019 |
Recalls mentioning this NDC
- D-0530-2026 Apr 22, 2026 · Class II
Lack of Assurance of Sterility
Other Bupivacaine Hydrochloride products
- 71351-022 Bupivacaine Hydrochloride 7.5 mg/mL · Injection · Brookfield Pharmaceuticals, LLC.
- 50090-4516 Bupivacaine Hydrochloride 5 mg/mL · Injection, Solution · A-S Medication Solutions
- 83854-006 Bupivacaine Hydrochloride 5 mg/mL · Injection, Solution · Anthea Pharma Private Limited
- 83854-005 Bupivacaine Hydrochloride 7.5 mg/mL · Injection, Solution · Anthea Pharma Private Limited
- 83854-004 Bupivacaine Hydrochloride 2.5 mg/mL · Injection, Solution · Anthea Pharma Private Limited
- 76420-579 Bupivacaine Hydrochloride 5 mg/mL · Injection, Solution · Asclemed USA, Inc.
- 76420-018 Bupivacaine Hydrochloride 2.5 mg/mL · Injection, Solution · Asclemed USA, Inc.
- 76420-008 Bupivacaine Hydrochloride 5 mg/mL · Injection, Solution · Asclemed USA, Inc.
- 76420-561 Bupivacaine Hydrochloride 5 mg/mL · Injection, Solution · Asclemed USA, Inc.
- 31722-277 Bupivacaine Hydrochloride 7.5 mg/mL · Injection, Solution · Camber Pharmaceuticals, Inc.
- 31722-276 Bupivacaine Hydrochloride 5 mg/mL · Injection, Solution · Camber Pharmaceuticals, Inc.
- 31722-275 Bupivacaine Hydrochloride 2.5 mg/mL · Injection, Solution · Camber Pharmaceuticals, Inc.